US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: Unveiling a 31% Potential Upside for Savvy Investors

Abbott Laboratories (NYSE: ABT), a venerable name in the healthcare sector, continues to be a compelling prospect for investors seeking both stability and growth. With its current market cap standing..

Bristol-Myers Squibb (BMY) Investor Outlook: A Look at Its 4.30% Dividend Yield and Growth Potential

For investors with an eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust dividend yield and potential for growth. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unveiling a 24% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry, stands out in the healthcare sector with its innovative cardiovascular solutions. Headquartered in Irvine, California, the company has..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 15.19% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers investors an intriguing opportunity for growth. With a market capitalization of $11.96 billion, this Ireland-based company has..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 32.58% Upside for Investors

Bio-Techne Corp (NASDAQ: TECH) stands as a key player in the biotechnology sector, developing and manufacturing life science reagents, instruments, and services for global markets. With a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 53% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing the attention of investors with a significant potential upside..

Insulet Corporation (PODD) Stock Analysis: Strong Growth Potential with a 72.78% Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in the development and sale of innovative insulin delivery systems. With a current market capitalization of $13.86 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 31.89% Upside Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a titan in the healthcare sector specializing in diagnostics and research, commands a significant presence in the veterinary diagnostics market. With a market capitalization of..

BioNTech SE (BNTX) Stock Analysis: Navigating a Complex Valuation with Promising Upside

BioNTech SE (NASDAQ: BNTX), a pioneer in the biotechnology space, has garnered significant attention for its role in developing mRNA-based therapies. With a market capitalization of $24.15 billion, this German..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing a 38.79% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, continues to capture investor attention with its extensive portfolio of clinical research services and healthcare intelligence solutions. The..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Analyzing the 16.90% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, has consistently positioned itself as a leader in the healthcare industry with its innovative treatments and robust pipeline...

argenx SE (ARGX) Investor Outlook: Navigating a Promising 28.89% Upside in Biotech

argenx SE (ARGX), a leading name in the biotechnology sector, is captivating investor attention with its robust market presence and promising growth prospects. Headquartered in the Netherlands, this commercial-stage biopharma..

Elevance Health, Inc. (ELV) Stock Analysis: A 22% Upside Potential Amidst Solid Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare sector, is currently drawing attention from the investment community. With a market capitalization of $68.76 billion, Elevance operates a broad..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a Promising 82.86% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a key player in the medical instruments and supplies industry, is turning heads among investors with a compelling 82.86% potential upside. With a market capitalization..

AptarGroup, Inc. (ATR) Stock Analysis: Unlocking a 23.74% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leader in the medical instruments and supplies industry, presents an enticing opportunity for investors looking for stable growth and reliable dividends within the healthcare sector...

Bio-Rad Laboratories, Inc. (BIO) Stock Report: Navigating Healthcare Innovation with an 8.33% Upside Potential

Investors with a keen eye on the healthcare sector may find Bio-Rad Laboratories, Inc. (NYSE: BIO) an intriguing prospect. With a market capitalization of $7.54 billion, this Hercules, California-based company..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth and a Strategic Edge in Healthcare

AstraZeneca PLC (NASDAQ: AZN), a leading entity in the healthcare sector, is making waves with its robust market position and strategic advancements in the biopharmaceutical industry. Currently boasting a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 23.89% Upside Potential

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), an established giant in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leading..

Ascendis Pharma A/S (ASND) Stock Analysis: High Buy Ratings and a Promising 22.56% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology company, continues to capture the attention of investors and analysts with its strong position in the healthcare sector. Specializing in the development..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds